Showing 1,821 - 1,840 results of 108,461 for search '(( 5 ((026 decrease) OR (a decrease)) ) OR ( a ((point decrease) OR (nn decrease)) ))', query time: 1.42s Refine Results
  1. 1821

    mFIZZ1′ and mFIZZ1 decreased the IL-13 and IL-5 secretion of splenocytes. by Wael Gad (285901)

    Published 2013
    “…Recombinant mFIZZ1′ and mFIZZ1 expressed with or without hQSOX1b were used at 200 ng/ml. rRa is the bacterial recombinant FIZZ1 (200 ng/ml) from (Peprotech) and PBS is the control. (<b>A</b>) Recombinant mFIZZ1′ and mFIZZ1 co-expressed with hQSOX1b significantly decreased the IL-5 secretion compared to the proteins expressed alone. …”
  2. 1822
  3. 1823
  4. 1824
  5. 1825
  6. 1826
  7. 1827
  8. 1828
  9. 1829

    Raw data of this study (SPSS). by Youngmin Ko (3333819)

    Published 2023
    “…The primary end point was a composite of biopsy-proven acute rejection, <i>de novo</i> donor-specific antibody formation, and graft failure.…”
  10. 1830

    Raw data of this study (EXCEL). by Youngmin Ko (3333819)

    Published 2023
    “…The primary end point was a composite of biopsy-proven acute rejection, <i>de novo</i> donor-specific antibody formation, and graft failure.…”
  11. 1831
  12. 1832
  13. 1833
  14. 1834
  15. 1835
  16. 1836

    A mt-tRNA<sup>Ser(UCN)</sup> point mutation, m.7480A>G, impairs i<sup>6</sup>A37 modification. by John W. Yarham (573109)

    Published 2014
    “…<b>B</b>) The i<sup>6</sup>A modification of position 37 is decreased (stronger binding of the mt-tRNA<sup>Ser(UCN)</sup> double ACL probe) by ∼86% in patient skeletal muscle relative to control muscle. …”
  17. 1837
  18. 1838
  19. 1839
  20. 1840